AT122298B - Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion. - Google Patents
Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion.Info
- Publication number
- AT122298B AT122298B AT122298DA AT122298B AT 122298 B AT122298 B AT 122298B AT 122298D A AT122298D A AT 122298DA AT 122298 B AT122298 B AT 122298B
- Authority
- AT
- Austria
- Prior art keywords
- cholesterol
- glands
- preparation
- free
- low
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
<Desc/Clms Page number 1>
Verfahren zur Darstellung von cholesterinfreien bzw.-armen Lösungen der wirksamen
Substanz aus Drüsen mit innerer Sekretion.
In dem österreichischen Patente Nr. 113810 ist ein Verfahren zur Darstellung von cholesterinfreien bzw. -armen Lösungen der wirksamen Ovarialsubstanz beschrieben, bei dem man als Reinigungs-bzw. Lösungsmittel wasserlösliche Äther und Ester mehrwertiger Alkohole verwendet.
Bei weiterer Bearbeitung dieses Arbeitsgebietes wurde nun die Beobachtung gemacht, dass das beschriebene Verfahren nicht auf die Darstellung von wirksamen Substanzen der Ovarialsubstanzen beschränkt ist, sondern dass auch bei Verwendung anderer Organe oder Drüsen mit innerer Sekretion die wasserlöslichen Äther und Ester mehrwertiger Alkohole als Abscheidungsmittel für Cholesterine oder andere Ballaststoffe sowie als Lösungsmittel der wirksamen Substanz mit Erfolg verwendet werden können.
Beispiele :
1. l/ Hpophysenvorderlappen werden zerkleinert und mit organischen Lösungsmitteln bei niederer Temperatur extrahiert. Die Konzentration des Gesamtextraktes beträgt ungefähr 60-700/0 an organischem Lösungsmittel. Nach Entfernung des Lösungsmittels wird das Rohkonzentrat in Äther aufgenommen. Die ätherische Lösung wird eingedampft und der Rückstand in Diäthylin gelöst. Durch Zusatz von Wasser, dessen Menge sich nach dem Cholesteringehalt des Ausgangsmaterials richtet, wird das Cholesterin in kristalliner Form abgeschieden. Das Filtrat enthält die wirksame Substanz und kann ohne weitere Reinigung verwendet werden.
2. 1 leg männliche Keimdrüsen werden nach üblicher Methode mit organischen Lösungsmitteln extrahiert und das Rohkonzentrat in Äther aufgenommen. Die Lösung wird hierauf durch Abdampfen von Äther befreit, der Rückstand in Diäthylin gelöst und aus dieser Lösung die vorhandenen Ballaststoffe durch fraktionierte Fällung mit Wasser entfernt. Die nach dem Abfiltrieren gewonnenen Flüssigkeiten enthalten die wirksamen Substanzen in gereinigter Form und können beliebig konzentriert werden.
**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.
<Desc / Clms Page number 1>
Process for the preparation of cholesterol-free or low-cholesterol solutions of the effective
Substance from glands with internal secretion.
In the Austrian patent no. 113810 a method for the preparation of cholesterol-free or low-cholesterol solutions of the active ovarian substance is described, in which one as a cleaning or. Solvent water-soluble ethers and esters of polyhydric alcohols are used.
In further processing of this field of work, the observation was made that the method described is not limited to the preparation of active substances of the ovarian substances, but that also when other organs or glands with internal secretion are used, the water-soluble ethers and esters of polyhydric alcohols as separating agents for cholesterol or other dietary fiber can be used with success as well as a solvent of the active ingredient.
Examples:
1. L / anterior pituitary lobes are crushed and extracted with organic solvents at low temperature. The concentration of the total extract is approximately 60-700 / 0 in organic solvent. After removing the solvent, the raw concentrate is taken up in ether. The ethereal solution is evaporated and the residue is dissolved in diethyline. By adding water, the amount of which depends on the cholesterol content of the starting material, the cholesterol is deposited in crystalline form. The filtrate contains the active substance and can be used without further purification.
2. 1 leg male gonads are extracted according to the usual method with organic solvents and the raw concentrate is taken up in ether. The solution is then freed from ether by evaporation, the residue is dissolved in diethyline and the dietary fibers present are removed from this solution by fractional precipitation with water. The liquids obtained after filtering off contain the active substances in purified form and can be concentrated as required.
** WARNING ** End of DESC field may overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE122298T | 1927-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AT122298B true AT122298B (en) | 1931-04-10 |
Family
ID=29277242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT122298D AT122298B (en) | 1927-01-11 | 1927-09-09 | Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion. |
Country Status (1)
Country | Link |
---|---|
AT (1) | AT122298B (en) |
-
1927
- 1927-09-09 AT AT122298D patent/AT122298B/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT122298B (en) | Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion. | |
DE384134C (en) | Process for the production of a chamomile extract | |
DE552820C (en) | Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from the anterior pituitary gland and male germ glands | |
CH349979A (en) | Process for the extraction and purification of sapogenins | |
DE701562C (en) | Method for purifying gonad hormones | |
DE545267C (en) | Process for the separate extraction of the hormones contained in the adrenal cortex | |
DE350377C (en) | Process for the extraction and purification of tannins | |
DE670923C (en) | Process for the purification of crude extracts of the corpus luteum hormone | |
DE430770C (en) | Process for the preparation of physiologically active substances | |
DE733809C (en) | Process for the extraction of glycosides from Strophanthus Kombe | |
AT118754B (en) | Process for the preparation of physiologically active substances from male internal secretory organs in a highly purified form. | |
DE670583C (en) | Method for purifying gonad hormones | |
DE663587C (en) | Process for the enrichment and purification of an activator that increases the male sex hormone effect | |
DE487199C (en) | Process for the preparation of purified tuberculin preparations | |
DE677844C (en) | Process for purifying extracts containing the adrenal cortex hormone | |
AT112461B (en) | Process for the extraction and excretion of tartaric acid from its raw materials. | |
DE651051C (en) | Purification process for the production of highly effective estrogenic substances from plant material | |
DE507794C (en) | Process for the preparation of glycerophosphates | |
DE537162C (en) | Process for the usable recovery of lupins | |
AT202712B (en) | Process for the extraction of alkaloids | |
DE637531C (en) | Process for the production of highly effective preparations from corpora lutea | |
AT144513B (en) | Method for excreting the follicular hormone from the urine of pregnant individuals. | |
DE483394C (en) | Process for the production of organophosphorus compounds from plant materials while preserving the vitamins | |
DE600400C (en) | Process for the production of growth hormones or their esters | |
DE414190C (en) | Process for the preparation of citric acid tribenzyl ester |